Predictive Factors of Failure or Success of Sedation With Dexmedetomidine in ICU

N/AUnknownNCT02200159

University Hospital, Clermont-Ferrand200 enrolled

Overview

Research predictive factors of success or failure of a sedation with Dexmedetomidine in ICU

Prospective clinical study in ICU with sedated ventilated patients with dexmedetomidine, establishing incidence of success, failure of moderate sedation or failure of dexmedetomidine, to evaluate the effectiveness of this drug sedation in moderate sedation

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Requiring Sedation in ICU Adult Patients Patient Covered by French Health Care System

Interventions

Sedation with dexmedetomidineDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: -Adult patients ventilated requiring sedation in ICU with RASS objective more than -2 Exclusion Criteria: * contraindication: intracranial lesion, hepatic failure * pregnancy

Locations (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, France

RECRUITING

Outcomes

Primary Outcomes

Number of patients with failure of sedation with dexmedetomidine

Number of patients with failure of sedation with dexmedetomidine (necessity to stop this sedation due to adverse event, RASS\>+1, other) in ICU patients requiring such sedation during ICU stay.

Time frame: at day 1

Secondary Outcomes

Incidence of adverse event of dexmedetomidine

Time frame: at day 1

Incidence of delirium and use of other sedative drugs

Time frame: at day 1

Central Contacts

Patrick LACARIN

CONTACT

04 73 75 11 95 placarin@chu-clermontferrand.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.